Allianz Se Biomarin Pharmaceutical Inc Call Options Transaction History
Allianz Se
- $3.84 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMRN
# of Institutions
648Shares Held
180MCall Options Held
2.03MPut Options Held
1.29M-
Black Rock Inc. New York, NY22.7MShares$1.5 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.2 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$915 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$856 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...